{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:50:51Z","timestamp":1787165451904,"version":"build-2736575974"},"reference-count":224,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Intern Med"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Next\u2010generation sequencing (\n                    <jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content>\n                    ) is rapidly changing the clinical care of patients with myelodysplastic syndrome (\n                    <jats:styled-content style=\"fixed-case\">MDS<\/jats:styled-content>\n                    ).\n                    <jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content>\n                    can be used for various applications: (i) in the diagnostic process to discriminate between\n                    <jats:styled-content style=\"fixed-case\">MDS<\/jats:styled-content>\n                    and other diseases such as aplastic anaemia, myeloproliferative disorders and idiopathic cytopenias; (ii) for classification, for example, where the presence of\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content>\n                      3B1\n                    <\/jats:italic>\n                    mutation is one criterion for the ring sideroblast anaemia subgroups in the World Health Organization 2016 classification; (iii) for identification of patients suitable for targeted therapy (e.g.\n                    <jats:styled-content style=\"fixed-case\">IDH<\/jats:styled-content>\n                    1\/2 inhibitors); (iv) for prognostication, for example, where specific mutations (e.g.\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>\n                      53\n                    <\/jats:italic>\n                    and\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">RUNX<\/jats:styled-content>\n                      1\n                    <\/jats:italic>\n                    ) are associated with inferior prognosis, whereas others (e.g.\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content>\n                      3B1\n                    <\/jats:italic>\n                    ) are associated with superior prognosis; and (v) to monitor patients for progression or treatment failure. Most commonly, targeted sequencing for genes (normally 50\u2013100 genes) reported to be recurrently mutated in myeloid disease is used. At present,\n                    <jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content>\n                    is rarely incorporated into clinical guidelines although an increasing number of studies have demonstrated the benefit of using\n                    <jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content>\n                    in the clinical management of\n                    <jats:styled-content style=\"fixed-case\">MDS<\/jats:styled-content>\n                    patients.\n                  <\/jats:p>","DOI":"10.1111\/joim.12893","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T10:11:23Z","timestamp":1552558283000},"page":"41-62","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Treatment of myelodysplastic syndrome in the era of next\u2010generation sequencing"],"prefix":"10.1111","volume":"286","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-5852","authenticated-orcid":false,"given":"M.","family":"Tobiasson","sequence":"first","affiliation":[{"name":"Department of Hematology Karolinska University Hospital Stockholm Sweden"},{"name":"Institution of Medicine Huddinge Karolinska Institute Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. O.","family":"Kittang","sequence":"additional","affiliation":[{"name":"Department of Clinical Science University of Bergen Bergen Norway"},{"name":"Section\u00a0for Hematology Department of Medicine Haukeland University Hospital Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-420489"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.336"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-08-518886"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301689"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-754796"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7899"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-082404"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.304"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1246725"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-700054"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12579"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.142695"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4906"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22510"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22602"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28663"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30016-4"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30228-4"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2018.046"},{"key":"e_1_2_7_21_1","first-page":"CD012055","article-title":"Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta\u2010analysis and systematic review","volume":"10","author":"Desborough M","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4149"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2012.07.004"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018019414"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1548::AID-CNCR16>3.0.CO;2-Y"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-277921"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414799"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061292"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-330126"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.8576"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.098103"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-139824"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.1669.1669"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30002-4"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.3168.3168"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25267"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.07.032"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4097"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.074831"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21792"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.9245"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1002650107"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-021162"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1605949"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0215"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.04.117"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21482"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.8"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24894"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.935366"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.6823"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.02.025"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-289280"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.5045\/br.2014.49.4.234"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-582809"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.269"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.71"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100206"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10526"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7290"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15490"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0907109106"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-429175"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4781"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.8.2957"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0080"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404796"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.170"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-203547"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.06.067"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31138"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00038-8"},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0313"},{"key":"e_1_2_7_74_1","unstructured":"WeiAH StricklandSA RobozGJet\u00a0al.Updated safety and efficacy results of phase 1\/2 study of venetoclax plus low\u2010dose cytarabine in treatment\u2010na\u00efve acute myeloid leukemia patients aged \u226565\u00a0years and unfit for standard induction therapy. EHA congress meeting 2017."},{"key":"e_1_2_7_75_1","unstructured":"DinardoCD PratzKW PotluriJet\u00a0al.Durable response with venetoclax in combination with decitabine or azacitadine in elderly patients with acute myeloid leukemia (AML). EHA congress meeting 2018."},{"key":"e_1_2_7_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-688796"},{"key":"e_1_2_7_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.26"},{"key":"e_1_2_7_78_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.039669"},{"key":"e_1_2_7_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.2510"},{"key":"e_1_2_7_80_1","doi-asserted-by":"crossref","unstructured":"KenealyM BensonW StevensonWet\u00a0al.The addition of Lenalidomide to azacitidine achieves higher responses but no improvement in twelve month clinical benefit or PFS; main analysis Australian allg MDS4 trial. Leukemia Research 2015.","DOI":"10.1016\/S0145-2126(15)30014-X"},{"key":"e_1_2_7_81_1","unstructured":"BengtRasmussen LN MartinJ MagnusTet\u00a0al.A randomized phase ii study of standard dose azacitidine alone or in combination with lenalidomide in high\u2010risk MDS with a karyotype including DEL(5Q). EHA congress meeting 2018."},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.7b00421"},{"key":"e_1_2_7_83_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2017-0392"},{"key":"e_1_2_7_84_1","doi-asserted-by":"crossref","unstructured":"Garcia\u2010ManeroG TallmanMS MartinelliG.Pembrolizumab a PD\u20101 inhibitor in patients with Myelodysplastic Syndrome (MDS) after failure of hypomethylating agent treatment. ASH Annual meeting abstract 2016.","DOI":"10.1182\/blood.V128.22.345.345"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4079"},{"key":"e_1_2_7_86_1","doi-asserted-by":"crossref","unstructured":"ZeidanA.Stabilization of Myelodysplastic Syndromes (MDS) Following Hypomethylating Agent (HMAs) Failure Using the Immune Checkpoint Inhibitor Ipilimumab: A Phase I Trial. ASH Annual meeting abstract 2015.","DOI":"10.1182\/blood.V126.23.1666.1666"},{"key":"e_1_2_7_87_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3324"},{"key":"e_1_2_7_88_1","article-title":"A phase II study evaluating the combination of nivolumab or ipilimumab with azacitidine in patients with previously treated or untreated myelodysplastic syndromes","author":"Garcia\u2010Manero G","year":"2016","journal-title":"Am Soc Hematol"},{"key":"e_1_2_7_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404316"},{"key":"e_1_2_7_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2405054"},{"key":"e_1_2_7_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.119"},{"key":"e_1_2_7_92_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110557"},{"key":"e_1_2_7_93_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110556"},{"key":"e_1_2_7_94_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.115840"},{"key":"e_1_2_7_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24972"},{"key":"e_1_2_7_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.07.004"},{"key":"e_1_2_7_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2015.10.005"},{"key":"e_1_2_7_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30383"},{"key":"e_1_2_7_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13323"},{"key":"e_1_2_7_100_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-789669"},{"key":"e_1_2_7_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00009-7"},{"key":"e_1_2_7_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011015)92:8<1999::AID-CNCR1538>3.0.CO;2-B"},{"key":"e_1_2_7_103_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1193"},{"key":"e_1_2_7_104_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30203"},{"key":"e_1_2_7_105_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4503"},{"key":"e_1_2_7_106_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.116715"},{"key":"e_1_2_7_107_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-423046"},{"key":"e_1_2_7_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23458"},{"key":"e_1_2_7_109_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0338"},{"key":"e_1_2_7_110_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.6.2079"},{"key":"e_1_2_7_111_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013343"},{"key":"e_1_2_7_112_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3742"},{"key":"e_1_2_7_113_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-542720"},{"key":"e_1_2_7_114_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-143735"},{"key":"e_1_2_7_115_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.3381"},{"key":"e_1_2_7_116_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-492884"},{"key":"e_1_2_7_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.05.010"},{"key":"e_1_2_7_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.06.022"},{"key":"e_1_2_7_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.01.009"},{"key":"e_1_2_7_120_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.3499"},{"key":"e_1_2_7_121_1","doi-asserted-by":"crossref","first-page":"12342","DOI":"10.18632\/oncotarget.12511","article-title":"Better transplant outcome with pre\u2010transplant marrow response after hypomethylating treatment in higher\u2010risk MDS with excess blasts","volume":"8","author":"Yahng SA","year":"2016","journal-title":"Oncotarget"},{"key":"e_1_2_7_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.12.016"},{"key":"e_1_2_7_123_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.179"},{"key":"e_1_2_7_124_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.234"},{"key":"e_1_2_7_125_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.7379"},{"key":"e_1_2_7_126_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.3616"},{"key":"e_1_2_7_127_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25064"},{"key":"e_1_2_7_128_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07697.x"},{"key":"e_1_2_7_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0074-7"},{"key":"e_1_2_7_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2018.07.010"},{"key":"e_1_2_7_131_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204218"},{"key":"e_1_2_7_132_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24332"},{"key":"e_1_2_7_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.04.013"},{"key":"e_1_2_7_134_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24901"},{"key":"e_1_2_7_135_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.4938"},{"key":"e_1_2_7_136_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00388a026"},{"key":"e_1_2_7_137_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0115-2"},{"key":"e_1_2_7_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2015.01.007"},{"key":"e_1_2_7_139_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-11-469619"},{"key":"e_1_2_7_140_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23882"},{"key":"e_1_2_7_141_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-0920-6"},{"key":"e_1_2_7_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.07.004"},{"key":"e_1_2_7_143_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1325"},{"key":"e_1_2_7_144_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-012-1521-3"},{"key":"e_1_2_7_145_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-333435"},{"key":"e_1_2_7_146_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-015-0605-z"},{"key":"e_1_2_7_147_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-014-0077-1"},{"key":"e_1_2_7_148_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.122"},{"key":"e_1_2_7_149_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.35"},{"key":"e_1_2_7_150_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214514"},{"key":"e_1_2_7_151_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22157"},{"key":"e_1_2_7_152_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.44"},{"key":"e_1_2_7_153_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19628"},{"key":"e_1_2_7_154_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.104406"},{"key":"e_1_2_7_155_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3177"},{"key":"e_1_2_7_156_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.621"},{"key":"e_1_2_7_157_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-3027-5"},{"key":"e_1_2_7_158_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.620"},{"key":"e_1_2_7_159_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-356352"},{"key":"e_1_2_7_160_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.913"},{"key":"e_1_2_7_161_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-447367"},{"key":"e_1_2_7_162_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-669937"},{"key":"e_1_2_7_163_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13317"},{"key":"e_1_2_7_164_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.298"},{"key":"e_1_2_7_165_1","doi-asserted-by":"publisher","DOI":"10.1159\/000479546"},{"key":"e_1_2_7_166_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.211"},{"key":"e_1_2_7_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.06.003"},{"key":"e_1_2_7_168_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23596"},{"key":"e_1_2_7_169_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2627-3"},{"key":"e_1_2_7_170_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3411-9"},{"key":"e_1_2_7_171_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611604"},{"key":"e_1_2_7_172_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3400"},{"key":"e_1_2_7_173_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.212"},{"key":"e_1_2_7_174_1","first-page":"853","article-title":"Mutations of PTPN11 are rare in adult myeloid malignancies","volume":"90","author":"Hugues L","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_7_175_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2004.10.001"},{"key":"e_1_2_7_176_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1156"},{"key":"e_1_2_7_177_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2731"},{"key":"e_1_2_7_178_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-518746"},{"key":"e_1_2_7_179_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-567057"},{"key":"e_1_2_7_180_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep43113"},{"key":"e_1_2_7_181_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-399337"},{"key":"e_1_2_7_182_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12491"},{"key":"e_1_2_7_183_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2696"},{"key":"e_1_2_7_184_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.133"},{"key":"e_1_2_7_185_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2495"},{"key":"e_1_2_7_186_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.301"},{"key":"e_1_2_7_187_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-400994"},{"key":"e_1_2_7_188_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-399774"},{"key":"e_1_2_7_189_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-377275"},{"key":"e_1_2_7_190_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.075325"},{"key":"e_1_2_7_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.05.016"},{"key":"e_1_2_7_192_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-843771"},{"key":"e_1_2_7_193_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10496"},{"key":"e_1_2_7_194_1","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2018.1471794"},{"key":"e_1_2_7_195_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25046"},{"key":"e_1_2_7_196_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-015-0009-y"},{"key":"e_1_2_7_197_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24306"},{"key":"e_1_2_7_198_1","first-page":"3081","article-title":"Mutations in the Spliceosomal Machinery Genes SRSF2, U2AF1, and ZRSR2 and Response to Decitabine in Myelodysplastic Syndrome","volume":"35","author":"Hong JY","year":"2015","journal-title":"Anticancer Res"},{"key":"e_1_2_7_199_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1493-5"},{"key":"e_1_2_7_200_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.04.006"},{"key":"e_1_2_7_201_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00202-15"},{"key":"e_1_2_7_202_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-412296"},{"key":"e_1_2_7_203_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-390252"},{"key":"e_1_2_7_204_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185053"},{"key":"e_1_2_7_205_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2413"},{"key":"e_1_2_7_206_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810069"},{"key":"e_1_2_7_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2017.03.013"},{"key":"e_1_2_7_208_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-215814"},{"key":"e_1_2_7_209_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.391"},{"key":"e_1_2_7_210_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-274704"},{"key":"e_1_2_7_211_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.21993"},{"key":"e_1_2_7_212_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.1031"},{"key":"e_1_2_7_213_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-480970"},{"key":"e_1_2_7_214_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1504940"},{"key":"e_1_2_7_215_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7042"},{"key":"e_1_2_7_216_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30680"},{"key":"e_1_2_7_217_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-480228"},{"key":"e_1_2_7_218_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.4888"},{"key":"e_1_2_7_219_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614359"},{"key":"e_1_2_7_220_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.48.8783"},{"key":"e_1_2_7_221_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30416-3"},{"key":"e_1_2_7_222_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716984"},{"key":"e_1_2_7_223_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-779405"},{"key":"e_1_2_7_224_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30615-0"},{"key":"e_1_2_7_225_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4493"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joim.12893","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/joim.12893","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joim.12893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T10:12:46Z","timestamp":1694081566000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/joim.12893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":224,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1111\/joim.12893"],"URL":"https:\/\/doi.org\/10.1111\/joim.12893","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"assertion":[{"value":"2019-03-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}